Non-Current Liabilities
Marketing and selling
Incyte Marketing and selling decreased by 9.1% to $64.76M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 20.5%, from $53.76M to $64.76M. Over 4 years (FY 2021 to FY 2025), Marketing and selling shows an upward trend with a 18.8% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
First reportedQ4 2021
Last reportedQ1 2026Apr 28, 2026
Metric ID:
non_current_liabilities_accrued_marketing_costs_currentHistorical Data
16 periods
| Q4 '21 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $35.75M | $31.00M | $31.15M | $60.67M | $29.01M | $36.70M | $37.37M | $41.97M | $39.54M | $40.60M | $33.44M | $53.76M | $51.31M | $48.91M | $71.25M | $64.76M |
| QoQ Change | — | -13.3% | +0.5% | +94.8% | -52.2% | +26.5% | +1.8% | +12.3% | -5.8% | +2.7% | -17.6% | +60.8% | -4.6% | -4.7% | +45.7% | -9.1% |
| YoY Change | — | — | -12.9% | — | — | +18.4% | +20.0% | -30.8% | +36.3% | +10.6% | -10.5% | +28.1% | +29.8% | +20.5% | +113.1% | +20.5% |
Range$29.01M – $71.25M
CAGR+17.2%
Avg YoY Growth+20.2%
Median YoY Growth+20.2%
Marketing and selling at Other Companies
Frequently Asked Questions
- What is Incyte's marketing and selling?
- Incyte (INCY) reported marketing and selling of $64.76M in Q1 2026.
- How has Incyte's marketing and selling changed year-over-year?
- Incyte's marketing and selling increased by 20.5% year-over-year, from $53.76M to $64.76M.
- What is the long-term trend for Incyte's marketing and selling?
- Over 4 years (2021 to 2025), Incyte's marketing and selling has grown at a 18.8% compound annual growth rate (CAGR), from $35.75M to $71.25M.